Leen Kawas, a successful biopharma entrepreneur, inventor, and inspiration, has significantly contributed to the healthcare industry. She is known for her innovative approach to developing treatments for rare diseases and has achieved several milestones in her career.
Leen received her Ph.D. in pharmacy from the University of Jordan and later completed her postdoctoral training in pharmaceutical sciences at the University of Florida. After her postdoctoral training, she worked as a researcher at several prestigious institutions, including the University of California, Los Angeles.
In 2015, Leen founded M3 Biotechnology, a biopharmaceutical company focusing on developing neurodegenerative disease treatments. She has been the driving force behind the company’s success, raising millions of dollars in funding and leading the development of its lead drug candidate, NDX-1017.
Leen Kawas has received several awards, including the 2018 Entrepreneur of the Year from the Seattle Business Magazine. She was also recognized as one of the “40 under 40” by the Puget Sound Business Journal in 2017.
In addition to her professional achievements, Leen Kawas inspires many due to her personal story. She is a mother of two and has overcome several challenges in her life, including discrimination and financial difficulties. Despite these challenges, she persevered and succeeded through hard work and determination.
Leen Kawas is also committed to giving back to her community. She is a board member of several non-profit organizations, including the Alzheimer’s Association, the Washington Biotechnology and Biomedical Association, and the Seattle Metropolitan Chamber of Commerce.
Leen Kawas is a successful biopharma entrepreneur, inventor, and inspiration who has significantly contributed to the healthcare industry. Her innovative approach to developing treatments for rare diseases and her personal story of overcoming challenges make her an inspiration to many.